Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Twist Bioscience Corporation

TWSTNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 19, 2026Accepted Aug 19, 2026, 2:25 PM EDTFiling CIK 1581280Accession 0001959173-26-006220
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
Twist Bioscience Corp
Issuer CIK
0001581280
SEC file number
001-38720
Phone
800-719-0671
Person for whose account securities are to be sold
Cho Dennis
Relationships to issuer
Officer
Street
681 GATEWAY BLVD.
City
SOUTH SAN FRANCISCO
State / country code
CA
Postal code
94080

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common14,2051,843,098.7562,707,42408/19/2026NASDAQFidelity Brokerage Services LLC

Broker / market maker — proposed row 1, entry 1

Name
Fidelity Brokerage Services LLC
Street
900 Salem Street
City
Smithfield
State / country code
RI
Postal code
02917

Acquisition of securities to be sold

Acquisition of securities to be sold · 2 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common10/01/2025Restricted Stock VestingIssuer11,910N10/01/2025Compensation
Common10/29/2025Restricted Stock VestingIssuer2,295N10/29/2025Compensation

Sales reported in the preceding three months

Sales reported in the preceding three months · 7 reported rows
SellerSecuritySale dateAmount soldGross proceeds
Dennis H. ChoCommon05/21/20261,64287,447.34
Dennis H. ChoCommon05/29/202614,205990,798.75
Dennis H. ChoCommon06/08/202640228,077.37
Dennis H. ChoCommon06/22/202634630,213.55
Dennis H. ChoCommon06/24/202614,2051,274,898.75
Dennis H. ChoCommon08/03/20261,07091,293.68
Dennis H. ChoCommon08/05/202614,2051,558,998.75

Seller — prior-sale row 1, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 2, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 3, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 4, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 5, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 6, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Seller — prior-sale row 7, entry 1

Name
Dennis H. Cho
Street
681 Gateway Blvd
City
South San Francisco
State / country code
CA
Postal code
94080

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
08/19/2026
Signed
/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Dennis Cho
Plan adoption dates
02/17/2026

Company context

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets. We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal - more experiments, more iterations, more chances for remarkable discoveries.

Current securities

Recent company filings

  1. 144 filingSep 21, 2026
  2. 144 filingSep 21, 2026
  3. 144 filingSep 21, 2026
  4. 4 filingSep 21, 2026
  5. 144 filingSep 17, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.